Academics & Research

Sri Shankara Cancer Hospital and Research Centre firmly believe that academic activities and high-quality oncological care go hand in hand. Our weekly tumour board meetings witness several intense discussions between all specialists and resident doctors to come up with the best treatment plan for the patients, these meetings double up as a great learning opportunity for our students. In addition to this, Saturdays are dedicated to academic activities such as journal club sessions, continuous professional education activities and guest lectures/panel discussions by eminent scientists, doctors and professionals from the industry.

We conduct several National Board of Examinations (NBE) and Rajiv Gandhi University of Health Sciences (RGUHS) recognized academic courses to nurture and train the future leaders in oncological care and research.

Under the guidance of eminent scientists of our Academic Advisory Board and Institutional Ethics Committee, our research wing is rapidly growing with collaborations with other research inclined national and international centres. 

Sri Shankara Cancer Foundation is also recognized by the Department of Scientific & Industrial Research, Government of India. 

 

Super Speciality Courses

Diplomate of National Board of Examinations (DNB) 

Sri Shankara Cancer Hospital and Research Centre has been recognised and accredited by the National Board of Examinations (NBE) to conduct Diplomate of the National Board (DNB) Post Graduate Degree Programmes in:

  • DNB - Radiotherapy 

  • DNB - Surgical Oncology 

  • DNB - Medical Oncology 

  • DNB - Gynaec-Oncology 

 

Fellowships 

Rajiv Gandhi University of Health Sciences has recognised Sri Shankara Cancer Hospital and Research Centre as a fellowship centre for 

  • Oral Onco-Surgery 

  • Breast Diseases 

  • Palliative Medicine 

  • Tumor Pathology 

  • Brachytherapy 

  • Clinical Onco-Pharmacy 

  • Onco-Nursing

  • Interventional Radiology (Autonomous Fellowship of SSCHRC)

 

PhD Programmes

Sri Shankara Cancer Hospital and Research Centre has an MoU with Maastricht University, Netherlands that enables our clinicians, scientists and staff to enroll in a PhD programme at the university while continuing their work at the hospital. 

To more about the PhD and other academic programmes, Contact: 

Dr. Kishore Murthy, Director of Academics and Quality

Dr. Kishore Murthy 

Director of Academics and Quality 

Phone: 080 - 26981033

Email: kmurthy@sschrc.org

 

Continuous Professional Education 

Sri Shankara Cancer Hospital and Research Centre regularly conducts continuous professional education programmes such as CME, CDE, CNE and Symposia to train and update both in house and external professionals in the field of oncology.

Past CMEs:

09.03.2014 - SSCHRC/CPE - 001 

Paediatric Oncology

11.05.2014 - SSCHRC/CPE - 002

Symposium on Modern Radiotherapy – Current Practices and Future Directions

09.08.2014 - SSCHRC/CPE - 003

An insight into Thyroid Malignancy

18.10.2014 - SSCHRC/CPE - 004 

Pink month – Breast Cancer Awareness

29.11.2014 - SSCHRC/CPE - 005

Approach to Modern Management of Lung Cancer

07.02.2015 - SSCHRC/CPE - 006

Cervical Cancer – New Perspectives

22.08.2015 - SSCHRC/CPE - 007

Perioperative Management of Abdominal Surgical Patients

12.09.2015 - SSCHRC/CPE - 008

Current Concepts in Management of Shoulder Pain

06.12.2015 - SSCHRC/CPE - 009

The first Shankara Conclave on Uro Oncology and MR based planning

20.02.2016 - SSCHRC/CPE - 010

Recent Advances in Neuro Oncology

09.04.2016 - SSCHRC/CPE - 011

Cancer Pain

18.04.2016 - SSCHRC/CPE - 012

Overview of Urological Malignancies

20.04.2016 - SSCHRC/CPE - 013

General Practitioners CME programme

21.05.2016 - SSCHRC/CPE - 014

SSCHRC Cancer Palliative Care Group Meet -1

30.07.2016 - SSCHRC/CPE - 015

CME on IV fluids

10.09.2016 - SSCHRC/CPE - 016

SSCHRC Cancer Palliative Care Group Meet - 2

30.09.2016 - SSCHRC/CPE - 017

Contouring Workshop

01.10.2016 - SSCHRC/CPE - 018

Challenges and Current Trends in Management of Head, Neck and Upper GI Malignancies 

19.08.2017 - SSCHRC/CPE - 019

Bridging the Gap in Oral Oncology 

02.09.2017 - SSCHRC/CPE - 020

Haematolymphoid Disorders

09.09.2017 and 10.09.2017 - SSCHRC/CPE - 021

Refresher course in Brachytherapy 

16.09.2017 - SSCHRC/CPE - 022

Dilemmas and Controversies in Thyroid Cancer and Surgery

25.09.2018 - SSCHRC/CPE - 023

Endometrial Pathology

19.01.2019 - SSCHRC/CPE - 024

Bangalore Palliative Care Initiative Group and SSCHRC Cancer Palliative Care Group Meet

18.08.2019 - SSCHRC/CPE - 025

Updates in Pediatric Oncology and Hematology – Oncology in Pediatric office Practice

24.08.2019 - SSCHRC/CPE - 026

Symposium on Maxillofacial Prosthesis

08.02.2020 - SSCHRC/CPE - 027 

Navigating the Challenges in the PATH of Gyn Oncology - CME in Gynaec Onco Pathology

06.02.2020 - SSCHRC/CPE - 028

A 2020 Vision of Onco Anaesthesia

For more details on Academic Programmes and Activities, Contact:

Academics and Research, Sri Shankara Cancer Hospital and Research Centre 

Ph: 080-26981001

Email: academics@sschrc.org | research@sschrc.org 

 

Research 

SSCHRC has a separate Research Wing with several research publications in National and International peer reviewed journals. Our Academic/Research Advisory Board and Institutional Ethics Committee members meet once in few months to discuss and mentor our research scientists and physicians in the following areas

  • Clinical trails

  • Preventive and Community Oncology Research

  • Research in Nuclear Medicine

  • Research in Radiotherapy

  • Research in Holistic Sciences and Cancer Care

  • Establishment of Biobank

  • Research in Molecular Biology

 

Completed Projects

APPROVED BY IEC on JANUARY 13th, 2017

SSCF/Res - 009

A randomized control   study to evaluate the effectiveness of turmeric   mouthwash on Oral Health Status, treatment induced Oral Mucositis and associated Oral Dysfunctions among patients with head and neck cancer.

SSCF/Res - 010

A Study on Cardiac Sparing Radiotherapy In Left Breast Carcinoma Patients - Dosimetric Comparison of Various Techniques

SSCF/Res - 011

Pilot Study of Radiation Dose Escalation In The Treatment of Carcinoma Esophagus undergoing Concurrent Chemoradiation

SSCF/Res - 012

Clinical profile of patients with triple negative breast carcinoma Trainee.

SSCF/Res - 013

Comparative Study of Dose to Small Bowel, Bone Marrow and Femur Between 3 Different Radiotherapy Techniques –3D Conformal Radiotherapy (3DCRT), Intensity Modulated Radiotherapy (IMRT) And Rotational Intensity Modulated Radiotherapy in The Treatment of Carcinoma Rectum

 

APPROVED BY IEC ON January 11th, 2019

SSCF/Res - 032

A study on the prescribing pattern and outcone measure for prophylactic Anti-Emetic medications in chemotherapy induced Nausea and Vomiting

SSCF/Res - 033

A study to assess the Management of hypertension for pre and post-operative care hypertensive cancer patients

SSCF/Res - 034

Utilization study of antibiotics in febrile neutropenic cancer patients with bacteraemia

SSCF/Res - 035

A prospective study on acute adverse effect profile of intravenous zoledronic acid in cancer patients

SSCF/Res - 036

A Study On Quality of Life and Assessment of Adverse Drug Reaction of Tyrosine Kinase Inhibitors in Management of Solid organ malignancies

Ongoing Projects

APPROVED BY IEC ON AUGUST 26TH, 2016

SSCF/Res - 001

Critical assessment and standardization of sentinel lymph node mapping in early endometrial cancer

SSCF/Res - 002

Study of Utility of MR Diffusion Tensor Imaging (Tractography) In Radiotherapy Planning for High Grade Gliomas

SSCF/Res - 003

Development of an in vivo immunocompromised mice model system using breast tumor specimens from patient samples

SSCF/Res - 004

Retrospective study to evaluate molecular markers of prognosis, treatment response and disease outcomes in breast cancer

 

APPROVED BY IEC ON JANUARY 13th, 2017

SSCF/Res - 005

Gamma probe-guided sentinel node Radiolocalization in cancer of anterior one third tongue and Buccal Mucosa / Gingivobuccal sulcus”

SSCF/Res - 006

Radiotherapy Dose escalation by Simultaneous Integrated Boost Radiotherapy (SIB), combined with chemotherapy for esophageal cancers – Toxicity & Early outcomes”

SSCF/Res - 007

Multidrug resistance protein imaging in lung - a mechanistic study” 

SSCF/Res - 008

Fluoride application - prevention for dental caries in radiation therapy patient for Head and neck cancer

 

APPROVED BY IEC ON MAY 26th, 2017

SSCF/Res - 014

Prevention of Cancer: A longitudinal Interventional study in  Gauribidanur Taluk

SSCF/Res - 015

Evaluation of Mesenchymal stem cells from oral precancerous lesions and OSCCs [Oral squamous cell carcinoma] towards development of novel biomarkers for efficient prediction of prognosis for oral cancer.

 

APPROVED BY IEC ON OCTOBER 27th, 2017

SSCF/Res - 016

Understanding the molecular mechanisms of acquired drug resistance in epithelial ovarian cancer

SSCF/Res - 017

Genetic and Epigenetic landscape of acquired chemoresistance in cancer

SSCF/Res - 018

Investigating N-glycomic dynamics in ovarian cancer metastasis

SSCF/Res - 019

Role of breast MRI in breast cancer patients receiving Neoadjuvant chemotherapy (NACT)

SSCF/Res - 020

Establishment of primary Breast Tumor 3D culture Models to assess response to Therapeutics in vitro

 

APPROVED BY IEC ON MARCH 23rd, 2018

SSCF/Res - 021

Customized 3D printed Titanium Implants for reconstruction of Maxilla and Mandible following Oral Cancer Surgery

 

APPROVED BY IEC ON AUGUST 3rd, 2018

SSCF/Res - 022

Development of a Novel Approach for detection and analysis of digital mammogram

SSCF/Res - 023

A comparative study of palpation guided lumpectomy, ultrasound guided lumpectomy and cavity shaving technique for attaining negative margins in breast conservation surgery

SSCF/Res - 024

Comparison of RENAL, PADUA, ABC and C-index scoring systems in predicting perioperative outcomes after nephron sparing surgery

 

APPROVED BY IEC ON JANUARY 11th, 2019

SSCF/Res - 025

Genomic studies of Oral Submucous Fibrosis

SSCF/Res - 026

Establishment of Indian GI cancer Biobank and examination of molecular landscape of Indian GI cancer

SSCF/Res - 027

Evaluation of BRCA 1 dysfunction and DNB damage repair (DDR) deficiency by estimation of BRCA 1 and other DNA damage repair proteins by multimodality testing in Epithelial ovarian cancer (EOC)

SSCF/Res - 028

Role of GA 68 PSMA CT in evaluating recurrence in previously treated patients with glioma of the brain

SSCF/Res - 029

Targetted Alpha Therapy – New beginnings

SSCF/Res - 030

Efficacy of topical alpha adrenergic vasoconstrictor in prevention of chemotherapy induced alopecia: A pilot study.

SSCF/Res - 031

A prospective Study to compare the efficacy of topical Morphine mouth wash with standard Benzydamine oral mouth wash in the management of Oral mucositis in patients undergoing head and neck radiotherapy or Concurrent chemoradiotherapy

 

APPROVED BY IEC ON JULY 20TH, 2019

SSCF/Res - 037

Development and evaluation of an intervention to enhance resilience in breast cancer

SSCF/Res - 038

Breast Cancer in Premenopausal women – Evaluation of the role of circulating steroid hormones in resistance to therapy St. Johns Research Institute, Bangalore.

SSCF/Res - 039

Randomized trial of preoperative chemotherapy followed by surgery and adjuvant chemoradiation versus preoperative chemoradiation followed by surgery and adjuvant chemoradiotherapy for locally advanced operable Adenocarcinoma of gastroesophageal junction or gastric carcinoma

SSCF/Res - 040

A study to assess the knowledge and experiences of workplace incivility and its impact among staff nurses in selected hospitals Bengaluru

 

APPROVED BY IEC ON DECEMBER 21ST 2019

SSCF/Res - 041

Critical Analysis of Adding Neoadjuvant Chemotherapy to Standard Regimen In Carcinoma Cervix Stage III C  and IVA

SSCF/Res - 042

A Pilot Study of the Role of Local Consolidative Radiotherapy Following Systemic Chemotherapy on Well Controlled Limited Metastatic Non Small Cell Lung Cancer

SSCF/Res - 043

A pilot study comparing chemo- radiotherapy versus neoadjuvant chemoradiation followed by surgery in locally advanced carcinoma cervix

SSCF/Res - 044

Microsatellite instability (MSI) in metastatic  gastrointestinal cancers

SSCF/Res - 045

Assessment of miRNA signature and its correlation with clinic-pathological profile of Indian colorectal cancer patients in a tertiary care hospital

SSCF/Res - 046

Molecular assessment of margins of oral squamous cell carcinoma and to determine its prognostic significance

SSCF/Res - 047

Study of stem cell biomarker in tumour and adjacent tissue in breast cancer to predict the prognosis

SSCF/Res - 048

Comparison of Salivary Amylase levels, Salivary Scintigraphy and Diffusion Weighted Magnetic Resonance Imaging in evaluation of Xerostomia in Carcinoma of Nasopharynx, Oropharynx, Hypopharynx and Larynx patients treated with Intensity Modulated Radiotherapy

SSCF/Res - 049

Prospective study of MRI based interfractional changes in position of intracavitary brachytherapy applicator with respect to urinary bladder, bowel and rectum during brachytherapy in patients with carcinoma cervix

PUBLICATIONS

SSCF/PBN - 001
Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling. 

Gera S, Kumar S S, Swamy SN, Bhagat R, Vadaparty A, Gawari R, Bhat R, Dighe RR.

J Endocr Soc. 2018 Dec 12;3(2):340-357. doi: 10.1210/js.2018-00272. 

 

SSCF/PBN - 002
Outcomes of Computed Tomography-Guided Image-Based Interstitial Brachytherapy for Cancer of the Cervix Using GEC-ESTRO Guidelines. 

Rishi KS, Alva RC, Kadam AR, Sharma S.

Indian J Surg Oncol. 2018 Jun;9(2):181-186. doi: 10.1007/s13193-018-0738-6. 

 

SSCF/PBN - 003
The Impact of Breast Cancer on the Patient and the Family in Indian Perspective.

Alexander A, Kaluve R, Prabhu JS, Korlimarla A, Srinath BS, Manjunath S, Patil S, Gopinath KS, Sridhar TS.

Indian J Palliat Care. 2019 Jan-Mar;25(1):66-72. doi: 10.4103/IJPC.IJPC_158_18.

 

SSCF/PBN - 004
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.

Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, Ce A, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS.

Tumour Biol. 2017 Mar;39(3):1010428317695028. doi: 10.1177/1010428317695028.

 

SSCF/PBN - 005
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study.

Ramaswamy A, Ostwal V, Pande N, Sharma A, Patil S, Thippeswamy R, Ghadyalpatil N, Roy R, Peshwe H, Poladia B, Rajamanickam D, Rangarajan B, Neelesh Reddy PR, Pandita V, Mukherjee A, Thoke A, Sarkar A, Satish CT, Shashidara H, Banavali SD.

South Asian J Cancer. 2019 Jan-Mar;8(1):22-26. doi: 10.4103/sajc.sajc_173_18.

 

SSCF/PBN - 006
Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.

Bhaskari J, Premalata CS, Shilpa V, Rahul B, Pallavi VR, Ramesh G, Krishnamoorthy L.

Tumour Biol. 2016 Jan;37(1):1017-23. doi: 10.1007/s13277-015-3891-3.

 

SSCF/PBN - 007
Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer.

Korlimarla A, Prabhu JS, Remacle J, Rajarajan S, Raja U, C E A, Srinath BS, Manjunath S, K S G, Correa M, M S N P, Sridhar TS.

PLoS One. 2016 Apr 4;11(4):e0153113. doi: 10.1371/journal.pone.0153113

 

SSCF/PBN - 008
Study of dosimetric properties of flattened and unflattened megavoltage x ray beam on high Z implant materials.

Rajamanickam T, Muthu S, Murugan P, Pathokonda M, Senthilnathan K, Arunai Nambi Raj N, Ramesh Babu P.

J Appl Clin Med Phys. 2018 Nov;19(6):265-273. doi: 10.1002/acm2.12451

 

SSCF/PBN - 009
The role of hybrid bone SPECT/CT imaging in the work-up of the limping patient: a symptom-based and joint-oriented review.

Mohan HK, Strobel K, van der Bruggen W, Gnanasegaran G, Kampen WU, Kuwert T, Van den Wyngaert T, Paycha F.

Eur J Hybrid Imaging. 2018;2(1):8. doi: 10.1186/s41824-018-0026-2.

SSCF/PBN - 010
Implementation and Evaluation of Phantomless Intensity Modulated Radiotherapy Delivery Verification Using FractionCHECK.

Reddy BR, Ravikumar M, Varatharaj C, Childress N, Vivek TR.

Gulf J Oncolog. 2019 Sep;1(31):26-35

 

SSCF/PBN - 011
Studies on Fundamental Interaction Parameters for Stainless Steel and Titanium Biomaterials Using Flattened and Un-Flattened Megavoltage X-Ray Beams.

Rajamanickam T, Muthu S, Murugan P, Pathikonda M, Senthilnathan K, Nambi Raj NA, Ramesh Babu P.

Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2485-2491 doi:10.31557/APJCP.2019.20.8.2485

 

SSCF/PBN - 012
An Assessment of Dosimetric Characteristics of Inline 2.5 Mega Voltage Unflattened Imaging X-Ray Beam.

Rajamanickam T, Muthu S, Murugan P, Dinesan C, Mekala C, Senthilnathan K, Arunai Nambi Raj N, Ramesh Babu P.

Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2531-2539. doi:10.31557/APJCP.2019.20.8.2531.

 

SSCF/PBN - 013
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.

Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS.

Transl Oncol. 2017 Aug;10(4):699-706. doi: 10.1016/j.tranon.2017.04.011.

SSCF/PBN - 014

High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers K Desai, M G Nair, J S Prabhu, A Vinod, A Korlimarla, S Rajarajan, Aiyappa, R S Kaluve, A Alexander, P S Hari, G Mukherjee, R V Kumar, S Manjunath, M Correa, B S Srinath, S Patil, M. S. N. Prasad, K. S. Gopinath, R N. Rao5, S M. Violette, P H. Weinreb & T. S. Sridhar

Cancer Medicine 2016; 5(8):2000–2011 doi: 10.1002/cam4.756

 

SSCF/PBN - 015
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.

Prabhu JS, Korlimarla A, Desai K, Alexander A, Raghavan R, Anupama C, Dendukuri N, Manjunath S, Correa M, Raman N, Kalamdani A, Prasad M, Gopinath KS, Srinath BS, Sridhar TS.

J Cancer. 2014 Jan 23;5(2):156-65. doi: 10.7150/jca.7668

 

SSCF/PBN - 016
Gemcitabine and nab-paclitaxel based regimen in advanced pancreatic carcinoma at tertiary cancer centre, Bangalore 

Satheesh Thungappa, P Shashidhara, Ravi Thippeswamy, Shekar Patil

Annals of Oncology, Volume 28, Issue suppl_3, June 2017, 

 

SSCF/PBN - 017
Outcomes in lung cancer: An experience from routine tertiary care setting. 

Thippeswamy R, Patil S, Prashanth P, Sateesh C T, Vittal T, Shashidhara H P, Haridas K M

Indian J Cancer 2017;54:276-9; DOI: 10.4103/0019-509X.21960

SSCF/PBN - 018

Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study

Anant RVikas ONikhil PAtul SShekar PRavi TNikhil GRakesh RHarish PBhavesh PDeepan RBharat RPR Neelesh RVimal PAshis MAniket TAbhijit SCT SatishH ShashidaraSD Banavali

South Asian J Cancer 2019; 8:1; 22-26; DOI: 10.4103/sajc.sajc_173_18

 

SSCF/PBN - 019

Slow Growing Nasal Mass - A Rare Finding of Pleomorphic Adenoma in the Nasal Cavity and Review of Surgical Methods 

Sanchitha C, Sreeram MP, Prabhat Y, Srinath BS

Acta Scientific Otolaryngology 2.6 (2020): 10-13.

SSCF/PBN - 020

Ectopic cervical thymoma: A diagnostic dilemma.

Kurpad V, Sreeram MP, Sasthry M.

Ann Indian Acad Otorhinolaryngol Head Neck Surg 2020;4:13-5.

 
 

Admissions Open for BSc Nursing 2020-21

Download the Application Form

Email the filled form to sscon@sschrc.org and academics@sschrc.org

Admissions Open for BSc Radiotherapy Technology - 2020-21

Download the Application Form

Email the filled form to  academics@sschrc.org

Visit the website of Sri Shankara College of Nursing to know more about our Nursing and Allied Health Sciences Programmes

photo_2019-10-21_18-13-57.jpg

We strive to be accessible to all at times of need. In sickness and in health,

we’re here for you and your loved ones.

 

You can reach out to us at:

Sri Shankara Cancer Hospital and Research Centre

 

1st Cross, Shankara Matt Premises, Shankarapuram,

Basavanagudi, Bengaluru, Karnataka 560004

 

queries@sschrc.org • 080-26981000 • 080-46484444

  • Facebook
  • YouTube
  • Twitter
  • LinkedIn Social Icon
  • Instagram

We are always eager to improve our services.

Help us serve you better.

Give us your 

Contact Us